Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3043% above fair value
$283.85+2.75 (+0.98%)
Close on Nov 16, 2026Market cap $66.02BP/E 39.3Yield 0.72%
Cardinal Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Cardinal Health
Cardinal Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?